Tesamorelin, Ipamorelin 10mg (Blend)

Overview of Tesamorelin, Ipamorelin 10mg (Blend)

Tesamorelin, Ipamorelin 10mg (Blend) is a dual-pathway peptide formulation designed for laboratory research involving coordinated regulation of the somatotropic axis. By combining a GHRH receptor agonist with a selective GHS-R1a receptor agonist, this blend allows structured investigation of complementary intracellular signaling cascades within controlled experimental systems.

Tesamorelin provides stabilized GHRH receptor activation, while Ipamorelin selectively engages the ghrelin receptor (GHS-R1a). Together, these peptides allow researchers to examine receptor-level synergy, endocrine pathway integration, and pulsatile signaling dynamics in vitro.

Supplied as a lyophilized sterile powder, Tesamorelin, Ipamorelin 10mg (Blend) is intended strictly for laboratory research applications.

Component Peptide Analysis

Tesamorelin

Tesamorelin is a synthetic GHRH analog engineered for enhanced stability in experimental systems. In laboratory research, Tesamorelin is studied for:

• Selective activation of the GHRH receptor (GHRH-R)

• Adenylate cyclase stimulation

• cAMP-dependent intracellular cascade activation

• Protein kinase A (PKA) signaling engagement

• Growth hormone gene transcription modeling

• Endocrine feedback loop analysis

Its receptor specificity allows researchers to isolate GHRH-mediated signaling independent of ghrelin-associated pathways.

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue (GHS) belonging to the GHRP family. In research models, Ipamorelin is utilized to examine:

• GHS-R1a (ghrelin receptor) activation

• Phospholipase C (PLC) signaling

• Intracellular calcium mobilization

• Growth hormone release pathway modeling

• Receptor pharmacodynamic evaluation

Ipamorelin’s selectivity enables investigation of ghrelin receptor signaling without significant interaction with other pituitary hormone systems in experimental models.

Coordinated Mechanism of Action (Research Context)

When studied together, Tesamorelin and Ipamorelin allow researchers to evaluate dual receptor activation within the somatotropic axis.

Laboratory investigations may explore:

• GHRH receptor–mediated cAMP/PKA signaling

• GHS-R1a–mediated Gq/PLC calcium signaling

• Receptor cross-talk and signal amplification

• Pulsatile growth hormone secretion modeling

• Intracellular second messenger integration

• Transcriptional coordination across endocrine pathways

By engaging distinct yet complementary receptors, this blend supports structured examination of how parallel signaling cascades converge within pituitary somatotroph cells.

Research Applications

Tesamorelin, Ipamorelin 10mg (Blend) is commonly referenced in laboratory investigations involving:

1. Hypothalamic–pituitary axis modeling

2. Receptor pharmacology studies

3. Intracellular second messenger cascade analysis

4. Somatotropic signaling pathway research

5. Endocrine feedback loop evaluation

6. Peptide-induced transcriptional modulation studies

7. Comparative GHRH vs. GHS signaling investigations

In molecular endocrinology laboratories, this dual-peptide system provides a comprehensive platform for examining integrated growth hormone axis signaling dynamics.

Researchers exploring peptide receptor biology frequently consult peer-reviewed databases such as the National Center for Biotechnology Information (NCBI) for foundational literature.

Stability and Laboratory Handling

Tesamorelin, Ipamorelin 10mg (Blend) is supplied in lyophilized sterile powder form to preserve molecular stability and minimize hydrolytic degradation prior to reconstitution.

Recommended laboratory handling guidelines include:

• Store under refrigerated conditions as specified

• Avoid repeated freeze–thaw cycles

• Reconstitute using sterile laboratory-grade solvent

• Follow institutional peptide handling protocols

Lyophilization ensures structural integrity and reproducibility across multi-phase research protocols.

Product Specifications

• Compounds: Tesamorelin, Ipamorelin

• Total Strength: 10mg

• Classification: Dual GHRH/GHS research peptide blend

• Form: Lyophilized sterile powder

• Appearance: White to off-white solid

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory research only

Analytical Verification

Each batch undergoes analytical verification to confirm identity and purity using validated laboratory methodologies, which may include:

• High-performance liquid chromatography (HPLC)

• Mass spectrometry analysis

• Sequence validation

• Batch-to-batch consistency testing

Lot numbers are assigned to support traceability within structured research documentation systems.

Broader Scientific Context

Tesamorelin, Ipamorelin 10mg (Blend) integrates two complementary receptor agonists to support multi-pathway investigation of endocrine signaling networks. By combining GHRH receptor activation with selective ghrelin receptor engagement, researchers can explore complex receptor interactions within somatotropic axis research.

This blend contributes to broader understanding of peptide–receptor pharmacology, intracellular signaling integration, and endocrine pathway coordination in laboratory biology.

Compliance Notice

Tesamorelin, Ipamorelin 10mg (Blend) is intended strictly for laboratory research use.

This product is not approved for human consumption, therapeutic application, or clinical use. It is sold exclusively for in vitro research, analytical testing, and scientific investigation by qualified professionals.